### 17539 Federal Register / Vol. 79, No. 60 / Friday, March 28, 2014 / Notices

teleconference may contact Mr. Aaron Yeow, Designated Federal Officer (DFO), via telephone at (202) 564–2050
or at yeow.aaron@epa.gov. General information about the CASAC, as well as any updates concerning the meeting announced in this notice, may be found on the EPA Web site at http:// www.epa.gov/casac

. **SUPPLEMENTARY INFORMATION :**  The CASAC was established pursuant to the Clean Air Act (CAA) Amendments of 1977, codified at 42 U.S.C. 7409(d)(2), to review air quality criteria and NAAQS and recommend any new NAAQS and revisions of existing criteria and NAAQS as may be appropriate. The CASAC shall also provide advice, information, and recommendations to the Administrator on the scientific and technical aspects of issues related to the criteria for air quality standards, research related to air quality, sources of air pollution, and of adverse effects which may result from various strategies to attain and maintain air quality standards. The CASAC is a Federal Advisory Committee chartered under the Federal Advisory Committee Act (FACA), 5 U.S.C., App. 2. Section 109(d)(1) of the CAA requires that the Agency periodically review and revise, as appropriate, the air quality criteria and the NAAQS for the six ‘‘criteria’’ air pollutants, including oxides of nitrogen. EPA is currently reviewing the primary (health-based) NAAQS for nitrogen dioxide (NO 2 ), as an indicator for health effects caused by the presence of oxides of nitrogen in the ambient air.

For purposes of the review of the oxides of nitrogen air quality criteria for health and the primary NAAQS for nitrogen dioxide, the CASAC Oxides of Nitrogen Primary National Ambient Air Quality Standards Review Panel was formed following a request for public nominations of experts (77 FR 63827– 63828) and met on March 12–13, 2014 (as noticed in 79 FR 8701–8703) to peer review EPA’s Integrated Science Assessment for Oxides of Nitrogen— Health Criteria (External Review Draft— November 2013) and Integrated Review Plan for the Primary National Ambient Air Quality Standards for Nitrogen Dioxide (External Review Draft)

. Information about these review activities may be found on the CASAC Web site at http://www.epa.gov/casac

. Pursuant to FACA and EPA policy, notice is hereby given that the Chartered CASAC and the CASAC Oxides of Nitrogen Primary NAAQS Review Panel will hold a public teleconference to discuss its draft reviews of these two EPA documents. The CASAC Oxides of Nitrogen Primary NAAQS Review Panel and the CASAC will comply with the provisions of FACA and all appropriate SAB Staff Office procedural policies.

Technical Contacts: Any technical questions concerning the Integrated Science Assessment for Oxides of Nitrogen—Health Criteria (External Review Draft—November 2013) should be directed to Dr. Molini Patel (patel.molini@epa.gov) and technical questions concerning the Integrated Review Plan for the Primary National Ambient Air Quality Standards for Nitrogen Dioxide (External Review Draft) should be directed to Ms. Beth Hassett-Sipple (hassett-sipple.beth@
epa.gov ). Availability of Meeting Materials: Prior to the meeting, the review documents, agenda and other materials will be accessible through the calendar link on the blue navigation bar at http:// www.epa.gov/casac/

.

Procedures for Providing Public Input: Public comment for consideration by EPA’s federal advisory committees and panels has a different purpose from public comment provided to EPA program offices. Therefore, the process for submitting comments to a federal advisory committee is different from the process used to submit comments to an EPA program office.

Federal advisory committees and panels, including scientific advisory committees, provide independent advice to EPA. Members of the public can submit comments for a federal advisory committee to consider as it develops advice for EPA. Interested members of the public may submit relevant written or oral information on the topic of this advisory activity, and/ or the group conducting the activity, for the CASAC to consider during the advisory process. Input from the public to the CASAC will have the most impact if it provides specific scientific or technical information or analysis for CASAC panels to consider or if it relates to the clarity or accuracy of the technical information. Members of the public wishing to provide comment should contact the DFO directly. Oral Statements: In general, individuals or groups requesting an oral presentation on a public teleconference will be limited to three minutes. Each person making an oral statement should consider providing written comments as well as their oral statement so that the points presented orally can be expanded upon in writing. Interested parties should contact Mr. Aaron Yeow, DFO, in writing (preferably via email) at the contact information noted above by April 30, 2014 to be placed on the list of public speakers. Written Statements: Written statements should be supplied to the DFO via email at the contact information noted above by April 30, 2014 so that the information may be made available to the Panel members for their consideration. Written statements should be supplied in one of the following electronic formats: Adobe Acrobat PDF, MS Word, MS PowerPoint, or Rich Text files in IBM– PC/Windows 98/2000/XP format. It is the SAB Staff Office general policy to post written comments on the Web page for the advisory meeting or teleconference. Submitters are requested to provide an unsigned version of each document because the SAB Staff Office does not publish documents with signatures on its Web sites. Members of the public should be aware that their personal contact information, if included in any written comments, may be posted to the CASAC Web site. Copyrighted material will not be posted without explicit permission of the copyright holder.

Accessibility: For information on access or services for individuals with disabilities, please contact Mr. Aaron Yeow at (202) 564–2050 or yeow.aaron@ epa.gov. To request accommodation of a disability, please contact Mr. Yeow preferably at least ten days prior to each meeting to give EPA as much time as possible to process your request.

Dated: March 20, 2014. Thomas H. Brennan, Deputy Director, EPA Science Advisory Staff Office.
[FR Doc. 2014–06958 Filed 3–27–14; 8:45 am]

**BILLING CODE 6560–50–P**

**ENVIRONMENTAL PROTECTION AGENCY** 

**[EPA–HQ–OPP–2014–0215; FRL–9907–97]**

**Registration Review; Pesticide Dockets Opened for Review and**  **Comment**

**AGENCY :**  Environmental Protection Agency (EPA).

**ACTION :**  Notice.

**SUMMARY :**  With this document, EPA is opening the public comment period for several registration reviews. Registration review is EPA’s periodic review of pesticide registrations to ensure that each pesticide continues to satisfy the statutory standard for registration, that is, the pesticide can perform its intended function without unreasonable adverse effects on human health or the environment. Registration review dockets contain information that will assist the public in understanding the types of information and issues that the


### 17540 Federal Register / Vol. 79, No. 60 / Friday, March 28, 2014 / Notices

Agency may consider during the course of registration reviews. Through this program, EPA is ensuring that each pesticide’s registration is based on current scientific and other knowledge, including its effects on human health and the environment. This document also announces the Agency’s intent not to open registration review dockets for endosulfan, tall oil fatty acids and K salts, thiophanate-ethyl, and thiazopyr. The registrants have decided not to support continued registration of these pesticides and, therefore, EPA is not planning to open dockets for these pesticides under the registration review program. EPA is also announcing the availability of an amended final work plan (FWP) for chlorinated isocyanurates.

**DATES :**  Comments must be received on or before May 27, 2014.

**ADDRESSES :**  Submit your comments identified by the docket identification (ID) number for the specific pesticide of interest provided in the table in Unit III.A., by one of the following methods:

• Federal eRulemaking Portal: http:// www.regulations.gov. Follow the online instructions for submitting comments. Do not submit electronically any information you consider to be Confidential Business Information (CBI) or other information whose disclosure is restricted by statute.

• Mail: OPP Docket, Environmental Protection Agency Docket Center (EPA/ DC), (28221T), 1200 Pennsylvania Ave. NW., Washington, DC 20460–0001.

• Hand Delivery: To make special arrangements for hand delivery or delivery of boxed information, please follow the instructions at http:// www.epa.gov/dockets/contacts.html.

Additional instructions on commenting or visiting the docket, along with more information about dockets generally, is available at http://www.epa.gov/dockets.

**FOR FURTHER INFORMATION CONTACT :**  For pesticide specific information contact: The Chemical Review Manager or Regulatory Action Leader identified in the table in Unit III.A. for the pesticide of interest.

For general information contact: Richard Dumas, Pesticide Re-Evaluation Division (7508P), Office of Pesticide Programs, Environmental Protection Agency, 1200 Pennsylvania Ave. NW., Washington, DC 20460–0001; telephone number: (703) 308–8015; fax number: (703) 308–8005; email address: dumas.richard@epa.gov.

**SUPPLEMENTARY INFORMATION :**  I. General Information A. Does this action apply to me?

This action is directed to the public in general, and may be of interest to a wide range of stakeholders including environmental, human health, farmworker, and agricultural advocates; the chemical industry; pesticide users; and members of the public interested in the sale, distribution, or use of pesticides. Since others also may be interested, the Agency has not attempted to describe all the specific entities that may be affected by this action. B. What should I consider as I prepare my comments for EPA?

1. Submitting CBI. Do not submit this information to EPA through regulations.gov or email. Clearly mark the part or all of the information that you claim to be CBI. For CBI information in a disk or CD–ROM that you mail to EPA, mark the outside of the disk or CD–ROM as CBI and then identify electronically within the disk or CD–ROM the specific information that is claimed as CBI. In addition to one complete version of the comment that includes information claimed as CBI, a copy of the comment that does not contain the information claimed as CBI must be submitted for inclusion in the public docket. Information so marked will not be disclosed except in accordance with procedures set forth in 40 CFR part 2.

2. Tips for preparing your comments. When submitting comments, remember
to:

i. Identify the document by docket ID number and other identifying information (subject heading, Federal Register date and page number).

ii. Follow directions. The Agency may ask you to respond to specific questions or organize comments by referencing a Code of Federal Regulations (CFR) part or section number.

iii. Explain why you agree or disagree; suggest alternatives and substitute language for your requested changes.

iv. Describe any assumptions and provide any technical information and/ or data that you used.

v. If you estimate potential costs or burdens, explain how you arrived at your estimate in sufficient detail to allow for it to be reproduced.

vi. Provide specific examples to illustrate your concerns and suggest alternatives.

vii. Explain your views as clearly as possible, avoiding the use of profanity or personal threats. viii. Make sure to submit your comments by the comment period deadline identified.

3. Environmental justice. EPA seeks to achieve environmental justice, the fair treatment and meaningful involvement of any group, including minority and/or low income populations, in the development, implementation, and enforcement of environmental laws, regulations, and policies. To help address potential environmental justice issues, the Agency seeks information on any groups or segments of the population who, as a result of their location, cultural practices, or other factors, may have atypical or disproportionately high and adverse human health impacts or environmental effects from exposure to the pesticides discussed in this document, compared to the general population. II. Authority

EPA is initiating its reviews of the pesticides identified in this document pursuant to section 3(g) of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) and the Procedural Regulations for Registration Review at 40 CFR part 155, subpart C. Section 3(g) of FIFRA provides, among other things, that the registrations of pesticides are to be reviewed every 15 years. Under FIFRA, a pesticide product may be registered or remain registered only if it meets the statutory standard for registration given in FIFRA section 3(c)(5). When used in accordance with widespread and commonly recognized practice, the pesticide product must perform its intended function without unreasonable adverse effects on the environment; that is, without any unreasonable risk to man or the environment, or a human dietary risk from residues that result from the use of a pesticide in or on food.
III. Registration Reviews A. What action is the agency taking?

As directed by FIFRA section 3(g), EPA is reviewing the pesticide registrations identified in the table in this unit to assure that they continue to satisfy the FIFRA standard for registration—that is, they can still be used without unreasonable adverse effects on human health or the environment. A pesticide’s registration review begins when the Agency establishes a docket for the pesticide’s registration review case and opens the docket for public review and comment. At present, EPA is opening registration review dockets for the cases identified in the following table.


### 17541 Federal Register / Vol. 79, No. 60 / Friday, March 28, 2014 / Notices

TABLE

### —R EGISTRATION 

### R EVIEW 

### D OCKETS 

### O PENING

Registration review case name and No. Docket ID No. Chemical review manager or regulatory action leader, telephone No., email address

Aminopyralid (Case 7267) ................................................ EPA–HQ–OPP–2013–0749 Veronica Dutch, (703) 308–8585, dutch.veronica@
epa.gov

. Azadioxabicyclooctane (Case 3023) ................................ EPA–HQ–OPP–2013–0604 Sandra O’Neill, (703) 347–0141, oneill.sandra@
epa.gov

. Bacillus licheniformis strain SB3086 (Case 6014) ........... EPA–HQ–OPP–2014–0184 Michael Glikes, (703) 305–6231, glikes.michael@
epa.gov

. Clopyralid (Case 7212) ..................................................... EPA–HQ–OPP–2014–0167 Steven Snyderman, (703) 347–024 9, snyderman.steven@epa.gov

. Fenamidone (Case 7033) ................................................. EPA–HQ–OPP–2014–0048 Christina Scheltema, (703) 308–2201

, scheltema.christina@epa.gov

. Formic acid (Case 6073) .................................................. EPA–HQ–OPP–2014–0105 Leonard Cole, (703) 305–5412, cole.leonard@epa.gov

. Imazethapyr (Case 7208) ................................................. EPA–HQ–OPP–2013–0774 Katherine St. Clair, (703) 347–877 8, stclair.katherine@
epa.gov

. Kaolin (Case 6039) ........................................................... EPA–HQ–OPP–2014–0107 Gina Burnett, (703) 605–0513, burnett.gina@epa.gov

. Lithium hypochlorite (Case 3084) ..................................... EPA–HQ–OPP–2013–0606 Donna Kamarei, (703) 347–0443, kamarei.donna@
epa.gov

. MCPA (Case 0017) .......................................................... EPA–HQ–OPP–2014–0180 Khue Nguyen, (703) 347–0248, nguyen.khue@epa.gov

. MCPB and salts (Case 2365) ........................................... EPA–HQ–OPP–2014–0181 Khue Nguyen, (703) 347–0248, nguyen.khue@epa.gov

. Organic esters of phosphoric acid (Case 4122) ............... EPA–HQ–OPP–2013–0373 SanYvette Williams, (703) 305–7702, williams.sanyvette@epa.gov

. Potassium hypochlorite (Case 5076) ............................... EPA–HQ–OPP–2014–0157 Donna Kamarei, (703) 347–0443, kamarei.donna@
epa.gov

. TAED (Case 5105) ........................................................... EPA–HQ–OPP–2013–0608 SanYvette Williams, (703) 305–7 702, williams.sanyvette@epa.gov

. Tepraloxydim (Case 7257) ............................................... EPA–HQ–OPP–2014–0246 Wilhelmena Livingston, (703) 308–80 25, livingston.wilhelmena@epa.gov

. Thiabendazole and salts (Case 2670) ............................. EPA–HQ–OPP–2013–0175 Ricardo Jones, (703) 347–0493, jones.ricardo@
epa.gov, Sandra O’Neill, (703) 347–0141, oneill.sandra@epa.gov

. Thiophanate-methyl and carbendazim (Case 2680) ........ EPA–HQ–OPP–2014–0004 Russell Wasem, (703) 305–6979, wasem.russell@
epa.gov, Sandra O’Neill, (703) 347–0141, oneill.sandra@epa.gov.

EPA is also announcing that it will not be opening dockets for endosulfan, tall oil fatty acids and K salts, thiophanate-ethyl, and thiazopyr. Since EPA published a cancellation order on November 10, 2010, announcing that the last endosulfan use will end on July 21, 2016 (75 FR 69065), endosulfan will not be evaluated under registration review. For tall oil fatty acids and K salts, thiophanate-ethyl, and thiazopyr, EPA will not be opening registration review dockets because these pesticides are not included in any products actively registered under FIFRA section 3. The Agency will take separate actions to cancel any remaining FIFRA section 24(c) Special Local Needs registrations with this active ingredient and to propose revocation of any affected tolerances that are not supported for import purposes only. Finally, EPA is announcing the availability of an amended FWP for chlorinated isocyanurates, docket ID number EPA– HQ–OPP–2012–0794. This FWP has been amended to incorporate a change to the data requirements for registration review. B. Docket Content

1. Review dockets. The registration review dockets contain information that the Agency may consider in the course of the registration review. The Agency may include information from its files including, but not limited to, the following information:

• An overview of the registration review case status.

• A list of current product registrations and registrants.

• Federal Register notices regarding any pending registration actions.

• Federal Register notices regarding current or pending tolerances.

• Risk assessments.

• Bibliographies concerning current registrations.

• Summaries of incident data.

• Any other pertinent data or information.

Each docket contains a document summarizing what the Agency currently knows about the pesticide case and a preliminary work plan for anticipated data and assessment needs. Additional documents provide more detailed information. During this public comment period, the Agency is asking that interested persons identify any additional information they believe the Agency should consider during the registration reviews of these pesticides. The Agency identifies in each docket the areas where public comment is specifically requested, though comment in any area is welcome.

2. Other related information. More information on these cases, including the active ingredients for each case, may be located in the registration review schedule on the Agency’s Web site at http://www.epa.gov/oppsrrd1/ registration

_review/schedule.htm

. Information on the Agency’s registration review program and its implementing regulation may be seen at http:// www.epa.gov/oppsrrd1/registration

_ review

.

3. Information submission requirements. Anyone may submit data or information in response to this document. To be considered during a pesticide’s registration review, the submitted data or information must meet the following requirements:

• To ensure that EPA will consider data or information submitted, interested persons must submit the data or information during the comment period. The Agency may, at its discretion, consider data or information submitted at a later date.

• The data or information submitted must be presented in a legible and


### 17542 Federal Register / Vol. 79, No. 60 / Friday, March 28, 2014 / Notices

useable form. For example, an English translation must accompany any material that is not in English and a written transcript must accompany any information submitted as an audiographic or videographic record. Written material may be submitted in paper or electronic form.

• Submitters must clearly identify the source of any submitted data or information.

• Submitters may request the Agency to reconsider data or information that the Agency rejected in a previous review. However, submitters must explain why they believe the Agency should reconsider the data or information in the pesticide’s registration review.

As provided in 40 CFR 155.58, the registration review docket for each pesticide case will remain publicly accessible through the duration of the registration review process; that is, until all actions required in the final decision on the registration review case have been completed. List of Subjects

Environmental protection, Pesticides and pests.

Dated: March 20, 2014. Richard P. Keigwin, Jr., Director, Pesticide Re-Evaluation Division, Office of Pesticide Programs.
[FR Doc. 2014–06814 Filed 3–27–14; 8:45 am]

**BILLING CODE 6560–50–P**

**FEDERAL RESERVE SYSTEM**

**Formations of, Acquisitions by, and Mergers of Bank Holding Companies** 

The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq. ) (BHC Act), Regulation Y (12 CFR part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below.

The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The applications will also be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States.

Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than April 2, 2014.

A. Federal Reserve Bank of Chicago (Colette A. Fried, Assistant Vice President) 230 South LaSalle Street, Chicago, Illinois 60690–1414:

1. Minier Financial, Inc. Employee Stock Ownership Plan with 401(k) Provisions, Minier, Illinois; to increase its ownership of Minier Financial, Inc., Minier, Illinois, from 37 percent to 51 percent, and thereby indirectly acquire shares of First Farmers State Bank, Minier, Illinois.

B. Federal Reserve Bank of Minneapolis (Jacqueline G. King, Community Affairs Officer) 90 Hennepin Avenue, Minneapolis, Minnesota 55480–0291:

1. Alerus Financial Corporation, Grand Forks, North Dakota, to acquire 100 percent of Private Bancorporation, Inc., Minneapolis, Minnesota, and thereby indirectly acquire Private Bank Minnesota, Minneapolis, Minnesota.

Board of Governors of the Federal Reserve System, March 25, 2014. Michael J. Lewandowski, Assistant Secretary of the Board.
[FR Doc. 2014–06930 Filed 3–27–14; 8:45 am]

**BILLING CODE 6210–01–P**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Agency for Healthcare Research and Quality** 

**Agency Information Collection Activities: Proposed Collection;**  **Comment Request**

**AGENCY :**  Agency for Healthcare Research and Quality, HHS.

**ACTION :**  Notice.

**SUMMARY :**  This notice announces the intention of the Agency for Healthcare Research and Quality (AHRQ) to request that the Office of Management and Budget (OMB) approve the proposed information collection project:

‘‘ Evaluation of the Educating the Educator (EtE) Workshop.’’ In accordance with the Paperwork Reduction Act of 1995, Public Law 104– 13 (44 U.S.C. 3506(c)(2)(A)), AHRQ invites the public to comment on this proposed information collection.

**DATES :**  Comments on this notice must be received by May 27, 2014.

**ADDRESSES :**  Written comments should be submitted to: Doris Lefkowitz, Reports Clearance Officer, AHRQ, by email at doris.lefkowitz@ahrq.hhs.gov.

Copies of the proposed collection plans, data collection instruments, and specific details on the estimated burden can be obtained from the AHRQ Reports Clearance Officer.

**FOR FURTHER INFORMATION CONTACT :**  Doris Lefkowitz, AHRQ Reports Clearance Officer, (301) 427–1477, or by email at doris.lefkowitz@ahrq.hhs.gov.

**SUPPLEMENTARY INFORMATION :**  Proposed Project Evaluation of the Educating the Educator (EtE) Workshop

AHRQ’s Educating the Educator (EtE) workshop training project is an Agency knowledge translation and dissemination project that aims to increase knowledge about and use of AHRQ’s EHC Program products among health care professionals. For the EtE project, AHRQ is sponsoring thedevelopment of an accredited, inperson, train-the-trainer workshop program for health care professionals to educate them on how to use AHRQ’s EHC Program materials and resources in shared decision making (SDM) withpatients/caregivers. As a train-thetrainer program, the workshop also provides education on effectively training other health care professionals to facilitate the dissemination of the key competencies taught by the program. Additionally, as part of the EtE project, a collection of new stand-alone tools are being developed to facilitate the implementation and use of AHRQ EHC Program materials. The new tools will be integrated into the EtE workshop training program and made available to workshop participants. These new tools also will be publicly-accessible through the AHRQ Web site for easy referral, access, and use by both workshop participants and other health care professionals.

AHRQ recognizes the importance of ensuring that its dissemination activities are useful, well implemented, and effective in achieving their intended goals. Therefore, an evaluation is associated with the EtE project. The EtE evaluation is comprised of two key components. One component has beendesigned to support both a processoriented formative evaluation and a summative (impact) evaluation of the EtE train-the-trainer workshop program.